Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Arizona.
Press releases published on July 1, 2025
ReproNovo Announces First Participant Included in U.S. Phase 2 Trial of RPN-001 for Male Infertility
GlobeNewswire
·
July 1, 2025
RPN-001 is a novel orally administered aromatase inhibitor being developed for the treatment of infertility in men with low serum testosterone No FDA-approved oral therapies currently exist for this underserved population LAUSANNE, Switzerland and …
Poor mental health, police cuts fueled pandemic spike in impaired-driving deaths
GlobeNewswire
·
July 1, 2025
ARLINGTON, Va., July 01, 2025 (GLOBE NEWSWIRE) -- A national mental health crisis and reductions in policing may have helped fuel an increase in impaired-driving deaths during the COVID-19 pandemic, while the role of more liberal alcohol policies was …
Rakovina Therapeutics Announces Intention to Amend Debentures and Warrants
GlobeNewswire
·
July 1, 2025
VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”) announces that it will apply to the TSX Venture Exchange (the “Exchange”) to amend the terms of certain outstanding warrants and …
Dyne Therapeutics Announces Pricing of $200.0 Million Public Offering of Common Stock
GlobeNewswire
·
July 1, 2025
WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the pricing of …
Public Pressure Mounts: Campaign Reaches 155,000 Families, Calls for Action to Solve Child Care Crisis
GlobeNewswire
·
July 1, 2025
OMAHA, Neb., June 30, 2025 (GLOBE NEWSWIRE) -- Amidst a child care crisis, We Care for Kids/Por todos los niños is marking three years of spreading awareness about the importance of quality and affordable child care through its statewide public education …
Mesoblast and FDA Align on Key Items for Revascor® Biologic License Application in Ischemic Heart Failure
GlobeNewswire
·
July 1, 2025
NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced alignment with the United States Food and Drug Administration (FDA) on items required …